Skip to main content
. 2020 Feb 11;2020(2):CD001122. doi: 10.1002/14651858.CD001122.pub5

Zakherah 2011.

Methods Parallel randomised controlled trial conducted in Women's Health Centre and Physiology Department, Assiut University, Egypt
Timing: January 2007 to December 2009
Participants 120 women randomised. Mean age of women in adjusted thermal dose group was 25.7 ± 5.9 years and in the fixed‐dose group was 25.4 ± 5.7 years
Inclusion criteria: PCOS (Rotterdam 2003); aged 18 to 38 years, clomiphene‐resistant, anovulatory infertility for 2 years or more, confirmed patent tubes, normal semen analysis from male partner
Exclusion criteria: Endocrine abnormalities or pelvic pathology
Interventions Adjusted thermal dose thermal dose based on ovarian volume (4 to 9 holes delivering a thermal dose of 480 to 1080 J per ovary) (n = 60), versus
Fixed 4‐puncture thermal dose 600 J per ovary regardless of size (n = 60)
 Monopolar diathermy set at 30 W x 5 secs x 4 punctures
Follow‐up for 6 months. If no pregnancy after 6 months then evaluated using second‐look laparoscopy for presence of adhesions
Outcomes Ovulation rate, menstrual cycle regularity, pregnancy. Serum AMH, FSH, AFC and ovarian volume
Notes Conflict of interest: not stated
Clinical trial registration number: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "assigned randomly" "computer generated random number table"
Allocation concealment (selection bias) Unclear risk No details provided
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk No details provided
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No details provided
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 60 women allocated to each group. Adjusted thermal dose group lost 2 women to follow‐up (no reasons provided) analysed 58 women. The fixed‐dose group lost 3 women to follow‐up (no reasons provided), analysed 57 women
Selective reporting (reporting bias) Unclear risk We could not retrieve the original protocol. Miscarriage rate reported but not prespecified in Methods
Other bias Low risk Groups balanced at baseline

AMH: anti‐Müllerian hormone; AFC: antral follicle count; BBT: basal body temperature; BMI: body mass index; CC: clomiphene citrate; FSH: follicle stimulating hormone; hMG: human menopausal (urinary) gonadotrophins; IUI: intra uterine insemination; J: joules; LH: luteinizing hormone; LOD: laparoscopic ovarian drilling; LOE: laparoscopic ovarian electrocautery; OCP: oral contraceptive pill; OHSS: ovarian hyperstimulation syndrome; PCOS: polycystic ovary syndrome; rFSH: recombinant follicle stimulating hormone; THL: transvaginal hydrolaparoscopy; TSH: thyroid stimulating hormone